|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 688.00 KRW | +3.77% |
|
-16.50% | -78.02% |
| 04-07 | ABION Announces Preclinical Data Showing IFN-? Antibody Fusion Abn202 Outperforms Trop2-Targeting ADCs | CI |
| 25-04-04 | Abion To Divest 5.9 Billion Won Worth Of Shares In Vivozon Inc | RE |
Company Valuation: Abion Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 85,498 | 273,810 | 126,828 | 163,611 | 200,458 | 282,017 |
| Change | - | 220.25% | -53.68% | 29% | 22.52% | 40.69% |
| Enterprise Value (EV) 1 | 102,397 | 240,792 | 114,431 | 167,986 | 214,505 | 253,683 |
| Change | - | 135.15% | -52.48% | 46.8% | 27.69% | 18.26% |
| P/E | -8.16x | -3.89x | -6.36x | -5.53x | -4.02x | -7.21x |
| PBR | -4.28x | 8.53x | 8.4x | 18.6x | 7.37x | 4.12x |
| PEG | - | -0x | 0.1x | -0.1x | -0.2x | 0.1x |
| Capitalization / Revenue | 42.9x | 167x | 50.6x | 128x | 264x | 320x |
| EV / Revenue | 51.4x | 147x | 45.7x | 132x | 282x | 288x |
| EV / EBITDA | -9.86x | -23.7x | -4.64x | -5.49x | -6.38x | -13.6x |
| EV / EBIT | -9.36x | -22.6x | -4.55x | -5.39x | -6.28x | -13.1x |
| EV / FCF | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -468.9 | -2,085 | -588.2 | -846.8 | -1,000 | -434.4 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | 1,994 | 1,638 | 2,507 | 1,274 | 759.7 | 880.1 |
| EBITDA 1 | -10,386 | -10,170 | -24,670 | -30,613 | -33,634 | -18,706 |
| EBIT 1 | -10,942 | -10,672 | -25,167 | -31,161 | -34,164 | -19,372 |
| Net income 1 | -10,476 | -54,259 | -19,925 | -29,211 | -43,381 | -29,063 |
| Net Debt 1 | 16,899 | -33,018 | -12,397 | 4,375 | 14,047 | -28,334 |
| Reference price 2 | 3,827.78 | 8,111.11 | 3,738.89 | 4,683.33 | 4,022.22 | 3,130.00 |
| Nbr of stocks (in thousands) | 22,336 | 33,757 | 33,921 | 34,935 | 49,838 | 90,101 |
| Announcement Date | 3/11/22 | 3/11/22 | 3/21/23 | 3/21/24 | 3/20/25 | 3/13/26 |
1KRW in Million2KRW
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| - | - | - | - | 43.3M | ||
| 17.93x | 5.93x | 12.15x | 1.71% | 56.7B | ||
| 30.64x | 7.55x | 23.21x | 0.05% | 51.97B | ||
| -18.24x | 4.35x | -7.62x | -.--% | 23.33B | ||
| -37.99x | 12.2x | -35.93x | -.--% | 21.34B | ||
| 24.11x | 4.7x | 15.27x | -.--% | 17.44B | ||
| 44.73x | 18.1x | 46.61x | 0.08% | 14.77B | ||
| 17.37x | 5.01x | 11.7x | -.--% | 13.84B | ||
| -26.49x | 25.4x | -31.82x | -.--% | 12.12B | ||
| -76.33x | 6.97x | -57.58x | -.--% | 11.14B | ||
| Average | -2.70x | 10.02x | -2.67x | 0.2% | 22.27B | |
| Weighted average by Cap. | 6.84x | 8.51x | 4.67x | 0.45% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- A203400 Stock
- Valuation Abion Inc.
Select your edition
All financial news and data tailored to specific country editions
















